Maximum toxicity to tumors.
Dosimetry-Guided Radiopharmaceutical Therapy (DG-RPT)
Fighting Cancer.
Making it Personal.
WHY IT MATTERS
For cancer patients, personalized radiopharmaceutical therapy (RPT) can mean increased tumor response, a higher quality of life and longer overall survival.
The Advantages of Dosimetry-Guided RPT
RPT provides an attractive alternative to chemotherapy, but one-size-fits-all dosing methods can result in under- or over-treatment. Dosimetry-guidance can unlock the full potential of RPT for patients.
Reduced damage to critical structures.
Improved survival.
Fewer side effects.
Torch™
GPU-Accelerated RPT Dose Assessment
Torch™ simplifies the otherwise complex task of analyzing a patient’s nuclear medicine scans to develop a personalized assessment, including estimates of patient-specific pharmacokinetics and calculation of dose to the patient’s tumors and critical structures.
NEWS & WEBINARS
- Sep 27, 2023
Voximetry Adds Experienced Healthtech Marketing Leader to Drive Growth
- Sep 20, 2023
Voximetry Selected As Preferred Provider of Advanced RPT Dose Assessment Services for Atherion Bioresearch CRO
- Sep 18, 2023
Voximetry Announces $5M Pre-A Financing to Advance Dosimetry Imaging Biomarker
- Sep 7, 2023
Voximetry Accelerates AI Technology Development with Strategic Technology Transfer Agreement